What is PIRRT Dialysis?
PIRRT (Prolonged Intermittent Renal Replacement Therapy), also known as PIKRT (Prolonged Intermittent Kidney Replacement Therapy), is a "hybrid" dialysis modality that combines characteristics of both intermittent hemodialysis and continuous renal replacement therapy, running for 6-12 hours per session (versus 3-4 hours for standard hemodialysis) but not continuously for 24 hours. 1
Key Characteristics
PIRRT is defined by several fundamental features 2, 3:
- Duration: Treatments last 6-12 hours per session (longer than standard intermittent hemodialysis but shorter than 24-hour continuous therapy)
- Frequency: Typically provided 4-7 times per week
- Technology: Can be delivered using either a modified intermittent hemodialysis machine or a CRRT machine
- Mechanism: Uses diffusion, convection, or a combination of both for solute removal
- Intensity: Decreased intensity of solute removal compared with standard intermittent hemodialysis
Clinical Advantages
PIRRT offers better hemodynamic stability, slower solute shifts, and improved tolerance of fluid removal compared to standard intermittent hemodialysis, making it preferentially used in critically ill patients with acute kidney injury and hemodynamic instability. 1
The specific advantages include 2, 4, 3:
- Hemodynamic stability: Gradual fluid removal over extended periods reduces cardiovascular stress
- Metabolic control: Better management of uremia, acid-base balance, and electrolyte disturbances
- Operational flexibility: Does not require 24-hour nursing supervision like CRRT
- Cost-effectiveness: Lower costs than continuous therapy while maintaining clinical efficacy
- Patient mobility: Allows for earlier patient mobilization compared to CRRT
- Reduced anticoagulation needs: May not require continuous anticoagulation
Clinical Context and Use
PIRRT is recommended as a reasonable alternative to CRRT in hemodynamically unstable adult patients, with no clear advantage demonstrated for CRRT over PIRRT in terms of patient outcomes. 1, 5, 1
The 2013 KDOQI guidelines specifically note that PIRRT modalities (also known as SLED - sustained low-efficiency dialysis, or EDD - extended duration dialysis) can be safely used in hemodynamically unstable adult patients 5. Clinical trials have generally demonstrated that PIRRT is non-inferior to CRRT regarding patient outcomes 4, 6.
Important Caveats
- Pediatric experience is extremely limited, precluding firm recommendations for this population 5
- Lack of standardization exists across institutions regarding prescription, technology, and delivery 4
- Drug dosing challenges persist due to variable treatment durations and frequencies 4, 7
- The choice between PIRRT, CRRT, and intermittent hemodialysis should be based on patient hemodynamic status, fluid removal needs, metabolic demands, and institutional resources 1